Company intelligence / Profile preview

Deltawave

Ownership: Private
Development stage: Commercial

Overview

Deltawave is building technology to automate the complete design process for small molecules and biologics, aiming to accelerate scientific discovery with artificial intelligence. The company positions itself as enabling "one-person biotechs" by providing tools that streamline early-stage R&D. There are no public disclosures of clinical results or advanced pipeline assets as of now.

Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Deltawave.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deltawave.

Explore the full profile